tirzepatide osteoporosis Tirzepatide, a dual GLP-1 and GIP receptor agonist, promotes bone loss in obese mice via gut microbial-related metabolites Misleading news on GLP-1s and

By potentiating GABA signaling, DSIP supports the neural quieting necessary for sleep onset and maintenance

Our product is tested specifically for LPS

Keep the vial wrapped in aluminum foil to protect from light exposure, which accelerates degradation

All dosing and administration must be prescribed and managed by a qualified physician

While data from clinical studies suggests that this peptide has a positive safety profile, there are several cases reported in the literature to show why experimentation with this peptide is limited to in vitro experimentation only [16]

Any off-label use should be guided strictly by a healthcare professional